Qsemble Capital Management’s Eli Lilly LLY Stock Holding History

Qsemble Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.94M	Sell	2,448 -7,090	-74%	-$7.24M	0.38%	94
2026 Q1	$8.77M	Buy	9,538 +8,530	+846%	+$8.65M	0.67%	35
2025 Q4	$1.08M	Buy	+1,008	New	+$964K	0.09%	266
2025 Q1	–	Sell	-452	Closed	-$349K	–	517
2024 Q4	$349K	Sell	452 -2,820	-86%	-$2.33M	0.05%	319
2024 Q3	$2.9M	Buy	+3,272	New	+$2.94M	0.53%	58
2023 Q4	–	Sell	-6,125	Closed	-$3.29M	–	423
2023 Q3	$3.29M	Buy	+6,125	New	+$3.16M	0.61%	58

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Qsemble Capital Management's LLY Position: Q2 2026 in Review

Qsemble Capital Management reduced its Eli Lilly (LLY) stake by 74% in Q2 2026, selling an estimated $7.24M and leaving 2,448 shares worth $2.94M. The position accounts for 0.38% of the portfolio, ranked #94.

Qsemble Capital Management first reported a position in LLY in Q3 2023 and has held it in 6 quarters since. The position peaked at $8.77M in Q1 2026. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Qsemble Capital Management held 2,448 shares of Eli Lilly worth $2.94M as of Q2 2026.
Qsemble Capital Management sold 7,090 Eli Lilly shares in Q2 2026, an estimated $7.24M.
Eli Lilly made up 0.38% of Qsemble Capital Management's portfolio in Q2 2026, its #94 holding.
Qsemble Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 6 quarters since.
Qsemble Capital Management's Eli Lilly position peaked at $8.77M in Q1 2026.
4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.